
1. autophagy. 2019 mar;15(3):493-509. doi: 10.1080/15548627.2018.1531196. epub 2018 
oct 18.

neuronal-targeted tfeb rescues dysfunction autophagy-lysosomal pathway and
alleviates ischemic injury permanent cerebral ischemia.

liu y(1), xue x(2), zhang h(1), che x(1), luo j(3), wang p(3), xu j(1), xing
z(1), yuan l(1), liu y(1), fu x(1), su d(1), sun s(1), zhang h(1), wu c(1), yang 
j(1).

author information: 
(1)a department pharmacology , shenyang pharmaceutical university , shenyang ,
china.
(2)b state key laboratory medicinal chemical biology , college pharmacy,
nankai university , tianjin , china.
(3)c gene engineering biotechnology, beijing key laboratory, college life 
sciences , beijing normal university , beijing , china.

mounting attention focused defects macroautophagy/autophagy and
the autophagy-lysosomal pathway (alp) cerebral ischemia. tfeb (transcription
factor eb)-mediated induction alp recently considered common
mechanism ameliorating pathological lesion myocardial ischemia and
neurodegenerative diseases. explored vital role tfeb permanent 
middle cerebral artery occlusion (pmcao)-mediated dysfunction alp ischemic
insult rats. results showed alp function first enhanced the
early stage ischemic process, especially neurons cortex, and
this accompanied increased tfeb expression translocation the
nucleus, mediated least part activation by
ppp3/calcineurin. later stages ischemia, gradual decrease the
level nuclear tfeb coupled progressive decline lysosomal
activity, accumulation autophagosomes autophagy substrates, and
exacerbation ischemic injury. notably, neuron-specific overexpression of
tfeb significantly enhanced alp function rescued ischemic damage,
starting early 6 h even lasting 48 h ischemia. furthermore,
neuron-specific knockdown tfeb markedly reversed activation alp and
further aggravated neurological deficits ischemic outcome early
stage pmcao. results highlight neuronal-targeted tfeb one key 
players pmcao-mediated dysfunction alp ischemic injury, and
identify tfeb promising target therapies aimed neuroprotection in
cerebral ischemia. abbreviations: aav, adeno-associated virus; aif1/iba1,
allograft inflammatory factor 1; alp, autophagy-lysosomal pathway; cq,
chloroquine; ctsb, cathepsin b; ctsd, cathepsin d; csa, cyclosporin a; gfap,
glial fibrillary acidic protein; lamp, lysosomal-associated membrane protein;
lc3, microtubule-associated protein 1 light chain 3; map2, microtubule-associated
protein 2; mnss, modified neurological severity score; mtor, mechanistic target
of rapamycin kinase; ogd, oxygen glucose deprivation; pmcao, permanent middle
cerebral artery occlusion; rbfox3/neun, rna binding fox-1 homolog 3; sqstm1,
sequestosome1; tfeb, transcription factor eb; ttc, 2,3,5-triphenyltetrazolium
chloride.

doi: 10.1080/15548627.2018.1531196 
pmcid: pmc6351122
pmid: 30304977  [indexed medline]

